Taku Kikuchi

499 total citations
57 papers, 335 citations indexed

About

Taku Kikuchi is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, Taku Kikuchi has authored 57 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 19 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in Taku Kikuchi's work include Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Taku Kikuchi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Taku Kikuchi collaborates with scholars based in Japan and United States. Taku Kikuchi's co-authors include Shinichiro Okamoto, Takehiko Mori, Jun Kato, Sumiko Kohashi, Takayuki Shimizu, Masatoshi Sakurai, Yuya Koda, Akiko Yamane, Takeshi Kobayashi and Hisashi Sakamaki and has published in prestigious journals such as Blood, Medicine and Endoscopy.

In The Last Decade

Taku Kikuchi

54 papers receiving 327 citations

Peers

Taku Kikuchi
Taku Kikuchi
Citations per year, relative to Taku Kikuchi Taku Kikuchi (= 1×) peers Mukul Aggarwal

Countries citing papers authored by Taku Kikuchi

Since Specialization
Citations

This map shows the geographic impact of Taku Kikuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taku Kikuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taku Kikuchi more than expected).

Fields of papers citing papers by Taku Kikuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taku Kikuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taku Kikuchi. The network helps show where Taku Kikuchi may publish in the future.

Co-authorship network of co-authors of Taku Kikuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Taku Kikuchi. A scholar is included among the top collaborators of Taku Kikuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taku Kikuchi. Taku Kikuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kikuchi, Taku, Hitoshi Sawada, Yu Abe, et al.. (2025). Can baseline cytomegalovirus IgG titers predict cytomegalovirus reactivation after ide-cel therapy?. Blood Advances. 9(18). 4716–4719.
2.
Kikuchi, Taku, Nobuhiro Tsukada, Hitoshi Sawada, et al.. (2025). Cytomegalovirus Retinitis During Idecabtagene Vicleucel Therapy in Patients With Relapsed/Refractory Multiple Myeloma. Transplant Infectious Disease. 27(4). e70040–e70040. 3 indexed citations
3.
Kikuchi, Taku, et al.. (2024). Cytomegalovirus Reactivation during Elotuzumab Therapy in Patients with Multiple Myeloma. Acta Haematologica. 148(1). 1–6. 1 indexed citations
4.
Kikuchi, Taku, et al.. (2024). Prognostic value of the “dynamic” R2‐ISS in patients with multiple myeloma undergoing anti‐CD38 antibody‐based triplet therapies. Hematological Oncology. 42(5). e3302–e3302. 1 indexed citations
5.
Kikuchi, Taku, Nobuhiro Tsukada, Yuki Oda, et al.. (2024). Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma. International Journal of Hematology. 120(1). 91–95. 1 indexed citations
6.
Kikuchi, Taku, Nobuhiro Tsukada, Yuki Oda, et al.. (2023). Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment. Annals of Hematology. 102(6). 1477–1483. 10 indexed citations
7.
Hasegawa, Yasushi, Hideaki Obara, Taku Kikuchi, et al.. (2023). Malignant lymphoma after liver transplantation for liver cirrhosis caused by human immunodeficiency virus and hepatitis C virus co-infection. Journal of Infection and Chemotherapy. 29(12). 1160–1163. 1 indexed citations
8.
Mori, Takehiko, Taku Kikuchi, Rie Yamazaki, et al.. (2021). Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 113(6). 877–883. 3 indexed citations
9.
Kikuchi, Taku, Takehiko Mori, Chikako Ohwada, et al.. (2020). Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine. International Journal of Hematology. 113(1). 128–133. 5 indexed citations
10.
Mori, Takehiko, Taku Kikuchi, Yuya Koda, et al.. (2020). Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening. Bone Marrow Transplantation. 56(6). 1266–1271. 9 indexed citations
11.
Sakurai, Masatoshi, Taku Kikuchi, Daiki Karigane, et al.. (2019). Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia. International Journal of Hematology. 109(3). 292–298. 17 indexed citations
12.
Mori, Takehiko, Taku Kikuchi, Jun Kato, et al.. (2019). Seasonal changes in indoor airborne fungal concentration in a hematology ward. Journal of Infection and Chemotherapy. 26(4). 363–366. 4 indexed citations
13.
Kohashi, Sumiko, Jun Kato, Taku Kikuchi, et al.. (2017). Single-institutional retrospective analysis of Japanese patients with chronic lymphocytic leukemia.. PubMed. 58(4). 282–286. 1 indexed citations
14.
Murakami, Koichi, Sumiko Kohashi, Masatoshi Sakurai, et al.. (2017). Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis. International Journal of Hematology. 106(3). 436–440. 12 indexed citations
15.
Kikuchi, Taku, et al.. (2017). Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide. Internal Medicine. 56(16). 2205–2211. 23 indexed citations
16.
Sakurai, Masatoshi, Taku Kikuchi, Jun Kato, et al.. (2017). Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography with gallium-67 scintigraphy in the initial clinical staging of diffuse large B-cell lymphoma. International Journal of Hematology. 107(2). 194–200. 3 indexed citations
17.
Asakura, Takanori, Makoto Ishii, Taku Kikuchi, et al.. (2016). Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma. Medicine. 95(11). e3131–e3131. 18 indexed citations
18.
Sakurai, Masatoshi, Takehiko Mori, Jun Kato, et al.. (2014). Efficacy of aprepitant in preventing nausea and vomiting due to high-dose melphalan-based conditioning for allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 99(4). 457–462. 8 indexed citations
19.
Kikuchi, Taku, Takeshi Kobayashi, Takuya Yamashita, et al.. (2010). Eight-year follow-up of patients with immune thrombocytopenic purpura related toH. pyloriinfection. Platelets. 22(1). 59–62. 29 indexed citations
20.
Takagi, Shinsuke, Taku Kikuchi, Hiroyuki Yokoyama, et al.. (2005). Significance of Colonoscopy in Patients with Intestinal Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation. Endoscopy. 37(4). 346–350. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026